Citadel Advisors »

Lisata Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Lisata Therapeutics (LSTA) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Lisata Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lisata Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lisata Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $39k 14k 2.73
2023-09-30 $39k 19k 2.09
2023-06-30 $64k 17k 3.70
2022-12-31 $31k 12k 2.49

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation Call Option (NVDA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Broadcom Call Option (AVGO)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl C Call Option (GOOG)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl A Call Option (GOOGL)

View all positions for Citadel Advisors

Top funds holding Lisata Therapeutics

BML Capital Management
Vanguard Group
BlackRock
Geode Capital Management
Cook Wealth Management Group
Dimensional Fund Advisors
Susquehanna International
HighTower Advisors
Bank of America Corporation
Morgan Stanley
Tower Research Capital
Founders Capital Management
Wells Fargo & Company
Royal Bank of Canada
Jpmorgan Chase & Co

View all funds holding Lisata Therapeutics